Institutional investors purchased a net $365.8 thousand shares of ENTA during the quarter ended December 2016. This may signal that the smart money is gaining interest in this company as the 72.31% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM LUXEMBOURG SA Bought 120.0 Thousand shares of Enanta Pharmaceuticals In...
CANDRIAM BELGIUM SA Bought 74.0 Thousand shares of Enanta Pharmaceuticals In...